Literature DB >> 16233019

Genetic and protein engineering of diagnostic enzymes, cholesterol oxidase and xylitol oxidase.

Y Murooka1, M Yamashita.   

Abstract

For a long time, clinical diagnosis has been made mainly using chemical methods. Recently, several excellent substrate-specific enzymes have been developed and these enzymes are used as diagnostic catalysts. Using enzymes, it is possible to assay for a specific substance from specimens of serum or urine without the need for isolation of the substance which simplifies the process and shortens the assay time. Furthermore, the use of enzymatic assay methods for diagnosis has been facilitated by the developments in genetic engineering which made it possible to overproduce enzymes inexpensively. Here, we review the diagnostic enzymes, cholesterol oxidase and xylitol oxidase, which were successfully overproduced in our laboratory. In particular, the catalytic activity and pH and thermal stabilities of cholesterol oxidase were improved.

Year:  2001        PMID: 16233019     DOI: 10.1263/jbb.91.433

Source DB:  PubMed          Journal:  J Biosci Bioeng        ISSN: 1347-4421            Impact factor:   2.894


  3 in total

1.  Formation of an Angular Aromatic Polyketide from a Linear Anthrene Precursor via Oxidative Rearrangement.

Authors:  Guixi Gao; Xiangyang Liu; Min Xu; Yemin Wang; Fei Zhang; Lijun Xu; Jin Lv; Qingshan Long; Qianjin Kang; Hong-Yu Ou; Ying Wang; Jürgen Rohr; Zixin Deng; Ming Jiang; Shuangjun Lin; Meifeng Tao
Journal:  Cell Chem Biol       Date:  2017-07-14       Impact factor: 8.116

Review 2.  The substrate tolerance of alcohol oxidases.

Authors:  Mathias Pickl; Michael Fuchs; Silvia M Glueck; Kurt Faber
Journal:  Appl Microbiol Biotechnol       Date:  2015-07-08       Impact factor: 4.813

3.  Secretory production of an FAD cofactor-containing cytosolic enzyme (sorbitol-xylitol oxidase from Streptomyces coelicolor) using the twin-arginine translocation (Tat) pathway of Corynebacterium glutamicum.

Authors:  Sandra Scheele; Dan Oertel; Johannes Bongaerts; Stefan Evers; Hendrik Hellmuth; Karl-Heinz Maurer; Michael Bott; Roland Freudl
Journal:  Microb Biotechnol       Date:  2012-11-20       Impact factor: 5.813

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.